company background image
BIOPOR logo

BioPorto CPSE:BIOPOR Stock Report

Last Price

DKK 1.49

Market Cap

DKK 640.2m

7D

-6.4%

1Y

-27.3%

Updated

26 Dec, 2024

Data

Company Financials +

BIOPOR Stock Overview

An in-vitro diagnostics company, provides biomarker tools and antibodies for clinical research in Europe, North America, Asia, and internationally. More details

BIOPOR fundamental analysis
Snowflake Score
Valuation0/6
Future Growth2/6
Past Performance0/6
Financial Health6/6
Dividends0/6

My Notes

Capture your thoughts, links and company narrative

BioPorto A/S Competitors

Price History & Performance

Summary of share price highs, lows and changes for BioPorto
Historical stock prices
Current Share PriceDKK 1.49
52 Week HighDKK 2.85
52 Week LowDKK 1.21
Beta1.17
1 Month Change-7.80%
3 Month Change-19.72%
1 Year Change-27.32%
3 Year Change-39.68%
5 Year Change-49.92%
Change since IPO-99.35%

Recent News & Updates

We're Hopeful That BioPorto (CPH:BIOPOR) Will Use Its Cash Wisely

Oct 22
We're Hopeful That BioPorto (CPH:BIOPOR) Will Use Its Cash Wisely

Recent updates

We're Hopeful That BioPorto (CPH:BIOPOR) Will Use Its Cash Wisely

Oct 22
We're Hopeful That BioPorto (CPH:BIOPOR) Will Use Its Cash Wisely

We Think BioPorto (CPH:BIOPOR) Needs To Drive Business Growth Carefully

Dec 25
We Think BioPorto (CPH:BIOPOR) Needs To Drive Business Growth Carefully

We Think BioPorto (CPH:BIOPOR) Needs To Drive Business Growth Carefully

Jun 28
We Think BioPorto (CPH:BIOPOR) Needs To Drive Business Growth Carefully

We're Hopeful That BioPorto (CPH:BIOPOR) Will Use Its Cash Wisely

Feb 27
We're Hopeful That BioPorto (CPH:BIOPOR) Will Use Its Cash Wisely

Companies Like BioPorto (CPH:BIOPOR) Are In A Position To Invest In Growth

Oct 19
Companies Like BioPorto (CPH:BIOPOR) Are In A Position To Invest In Growth

We're Keeping An Eye On BioPorto's (CPH:BIOPOR) Cash Burn Rate

Jun 15
We're Keeping An Eye On BioPorto's (CPH:BIOPOR) Cash Burn Rate

Is BioPorto (CPH:BIOPOR) In A Good Position To Deliver On Growth Plans?

Feb 17
Is BioPorto (CPH:BIOPOR) In A Good Position To Deliver On Growth Plans?

Here's Why We're Not Too Worried About BioPorto's (CPH:BIOPOR) Cash Burn Situation

Oct 16
Here's Why We're Not Too Worried About BioPorto's (CPH:BIOPOR) Cash Burn Situation

Companies Like BioPorto (CPH:BIOPOR) Are In A Position To Invest In Growth

May 28
Companies Like BioPorto (CPH:BIOPOR) Are In A Position To Invest In Growth

BioPorto A/S' (CPH:BIOPOR) Path To Profitability

Mar 01
BioPorto A/S' (CPH:BIOPOR) Path To Profitability

We Think BioPorto (CPH:BIOPOR) Needs To Drive Business Growth Carefully

Jan 24
We Think BioPorto (CPH:BIOPOR) Needs To Drive Business Growth Carefully

A Look At BioPorto's (CPH:BIOPOR) CEO Remuneration

Dec 20
A Look At BioPorto's (CPH:BIOPOR) CEO Remuneration

The BioPorto A/S (CPH:BIOPOR) Analysts Have Been Trimming Their Sales Forecasts

Nov 23
The BioPorto A/S (CPH:BIOPOR) Analysts Have Been Trimming Their Sales Forecasts

BioPorto A/S (CPH:BIOPOR) Analysts Are Cutting Their Estimates: Here's What You Need To Know

Nov 21
BioPorto A/S (CPH:BIOPOR) Analysts Are Cutting Their Estimates: Here's What You Need To Know

Shareholder Returns

BIOPORDK BiotechsDK Market
7D-6.4%-0.6%-9.0%
1Y-27.3%-10.3%-5.3%

Return vs Industry: BIOPOR underperformed the Danish Biotechs industry which returned -8.9% over the past year.

Return vs Market: BIOPOR underperformed the Danish Market which returned -4.9% over the past year.

Price Volatility

Is BIOPOR's price volatile compared to industry and market?
BIOPOR volatility
BIOPOR Average Weekly Movement6.6%
Biotechs Industry Average Movement7.5%
Market Average Movement4.4%
10% most volatile stocks in DK Market10.2%
10% least volatile stocks in DK Market2.8%

Stable Share Price: BIOPOR's share price has been volatile over the past 3 months compared to the Danish market.

Volatility Over Time: BIOPOR's weekly volatility (7%) has been stable over the past year, but is still higher than 75% of Danish stocks.

About the Company

FoundedEmployeesCEOWebsite
191736Peter Eriksenbioporto.com

BioPorto A/S, an in-vitro diagnostics company, provides biomarker tools and antibodies for clinical research in Europe, North America, Asia, and internationally. It offers the neutrophil gelatinase-associated lipocalin test, a quantitative particle-enhanced turbidimetric immunoassay designed to run on automated clinical chemistry analyzers; monoclonal antibodies for scientific, pharmaceutical, and clinical research; and enzyme-linked immunosorbent assay kits, as well as generic rapid assay device for custom lateral flow assays. BioPorto A/S was incorporated in 1917 and is based in Hellerup, Denmark.

BioPorto A/S Fundamentals Summary

How do BioPorto's earnings and revenue compare to its market cap?
BIOPOR fundamental statistics
Market capDKK 640.19m
Earnings (TTM)-DKK 61.30m
Revenue (TTM)DKK 34.91m

18.3x

P/S Ratio

-10.4x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
BIOPOR income statement (TTM)
RevenueDKK 34.91m
Cost of RevenueDKK 10.05m
Gross ProfitDKK 24.86m
Other ExpensesDKK 86.16m
Earnings-DKK 61.30m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

Mar 20, 2025

Earnings per share (EPS)-0.14
Gross Margin71.22%
Net Profit Margin-175.62%
Debt/Equity Ratio0%

How did BIOPOR perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/26 09:26
End of Day Share Price 2024/12/23 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

BioPorto A/S is covered by 3 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
null nullBrookline Capital Markets
Jyoti PrakashEdison Investment Research
Yi ChenH.C. Wainwright & Co.